Adjuvante and neoadjuvant therapy in colon and rectum carcinoma;Adjuvante und neoadjuvante Therapie beim Kolon- und Rektumkarzinom

Chirurgische Gastroenterologie mit Interdisziplinaren Gesprachen

Volumn 13, Issue 1, 1997, Pages 37-44

  Rau, B ^a   Schlag, P M ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

colon carcinoma; rectal carcinoma; therapy (adjuvant, neoadjuvant)

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; COLON CARCINOMA; HUMAN; MULTIMODALITY CANCER THERAPY; RECTUM CARCINOMA; REVIEW;

EID: 0030896118     PISSN: 01779990     EISSN: None     Source Type: Journal    
DOI: 10.1159/000190030     Document Type: Review

References (86)

1. Hermanek P Jr, Wiebelt H, Staimmer D, Hermanek P, SGKRK: Langzeitergebnisse der chirurgischen Therapie des Coloncarcinoms. Ergebnisse der Studiengruppe Kolorektales Karzinom (SGKRK). Chirurg 1994;65:287-297.
2. Rich T, Gunderson LL, Lew R, Galbidini JJ, Cohen AM, Donaldson G: Patterns of recurrence of rectal cancer after potentially curative surgery. Cancer 1983;52:1317-1329.
3. Duncan W, Smith AN, Freedman LF, et al: Clinico-pathological features of prognostic (significance in operable rectal cancer in 17 centres in the UK. Br J Surg 1984;50:435-442.
4. Phillips RK, Hittinger R, Blesovsky L, Fry JS, Fielding LP: Local recurrence following 'curative' surgery for large bowel cancer: II. The rectum and rectosigmoid. Br J Surg 1984;71:17-20.
5. Pilipshen SJ, Heilweil M, Quan SH, Sternberg SS, Enker WE: Patterns of pelvic recurrence following definitive resection of rectal cancer. Cancer 1984;53:1354-1362.
6. Enker WE, Heilweil ML, Hertz RE, Pilipshen SJ, Maus WS, Sternberg S, Janov AJ: En bloc pelvic lymphadenectomy and sphincter preservation in surgical management of rectal cancer. Ann Surg 1986;203:426-433.
7. Paty PB, Enker WE, Cohen AM, Lauwers GY: Treatment of rectal cancer by low anterior resection with coloanal anastomosis. Ann Surg 1994; 219:365-373.
8. Adam IJ, Mohamdee MO, Martin IG, Scott N, Finan PJ, Johnston D, Dixon MF, Quirke P: Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 1994;344: 707-711.
9. Cohen JL, Grotz RL, Welch JP, Deckers PJ: Intrarectal sonography. A new technique for the assessment of rectal tumors. Ann Surg 1991; 213:459-462.
10. Beynon J, Mortensen NJ, Channer JL, Rigby H: Rectal endosonography accurately predicts depth of penetration in rectal cancer. Int J Colorectal Dis 1992;7:4-7.
11. Glaser F, Kuntz C, Schlag P, Herfarth C: Endorectal ultrasound for control of preoperative radiotherapy of rectal cancer. Ann Surg 1993;217: 64-71.
12. Kuntz C, Glaser F, Schlag P: Value of endorectal ultrasound in the early detection of local recurrency of rectal tumors. J Cancer Res Clin Oncol 1992;118:R36.
13. Labianca R, Marsoni S, Pancera G, Torri V, Zaniboni A, Erlichman C, Pater J, Shepherd L, Zee B, Seitz JF, Milan C, Pignon JP, International multicentre pooled analysis of colon cancer trials (IMPACT) investigators: Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet 1995;345:939-944.
14. Wolmark N, Fisher B, Rockette H, Redmond C, Wickerham DL, Fisher ER, Jones J, Glass A, Lerner H, Lawrence W, et al: Postoperative adjuvant chemotherapy or BCG for colon cancer: Results from NSABP protocol C-01. J Natl Cancer Inst 1988;80:30-36.
15. Laune JA, Moertel CG, Fleming TR, Wieand HS, Leigh JE, Rubin J, McCormack GW, Gerstner JB, Krook JE, Malliard J, Twito DI, Morton RF, Tschetter LK, Barlow JF, North Central Cancer Treatment Group: Surgical adjuvant therapy of larg-bowel carcinoma: An evaluation of Levamisole and the combination of Levamisole and Fluorouracil. J Clin Oncol 1989;7:1447-1456.
16. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA: Hepatic toxicity associated with Fluorouracil plus Levamisole adjuvant therapy. J Clin Oncol 1993;11:2386-2390.
17. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Goodman PJ, Ungerleider JS, Emerson WA, Tormey DC, Glick JH, Veeder MH, Mailliard JA: Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990;322:352-358.
18. O'Connell MJ, Mailliard JA, Macdonald JS, Haller D, Mayer RJ, Wieand HS: An intergroup trial of intensive course 5-FU and low dose Leucovorin as surgical adjuvant therapy for high risk colon cancer. Proc ASCO 1993;12:190.
19. Wolmark N, Rockette H, Fisher B, Wickerham DL, Redmond C, Fisher ER, Jones J, Mamounas EP, Ore L, Petrelli NJ, et al: The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: Results from National Surgical Adjuvant Breast and Bowel Project protocol C-03. J Clin Oncol 1993;11:1879-1887.
20. Francini G, Petrioli R, Lorenzini L, Mancini S, Armenio S, Tanzini G, Marsili S, Aquino A, Marzocca G, Civitelli S, et al: Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer. Gastroenterology 1994;106:899-906
21. Hardcastle JD: Detection of colorectal liver metastases using intraoperative ultrasonography. Br J Surg 1991;78:45-48.
22. Findlay IG, McArdle CS: Effect of occult metastases on survival after curative resection for colorectal carcinoma. Gastroenterology 1983;85: 596-599.
23. Taylor I, Machin D, Mullee M, et al: A randomized controlled trial of adjuvant portal vein cytotoxic perfusion in colorectal cancer. Br J Surg 1985;72:359-362.
24. Wolmark N, Rockette H, Wickerham DL, Fisher B, Redmond C, Fisher ER, Potvin M, Davies RJ, Jones J, Robidoux A, et al: Adjuvant therapy of Dukes' A, B, and C adenocarcinoma of the colon with portal-vein fluorouracil hepatic infusion: Preliminary results of National Surgical Adjuvant Breast and Bowel Project protocol C-02. J Clin Oncol 1990;8:1466-1475.
25. Swiss Group for Clinical Cancer Research (SAKK): Long-term results of single course of adjuvant intraportal chemotherapy for colorectal cancer. Lancet, 1995;345:349-353
26. Metzger U, Mermillod B, Aeberhard P, Gloor F, Bissat A, Egeli R, Laffer U, Martinoli S, Mueller W, Schroeder R, et al: Intraportal chemotherapy in colorectal carcinoma as an adjuvant modality. World J Surg 1987;11:452-458.
27. Wereldsma JC, Bruggink EDM, Meijer WS, Roukema JA, Putten J: Adjuvant portal liver infusion in colorectal cancer with 5-Fluorouracil/ Heparin versus Urokinase versus control. Cancer 1990,65:425-432.
28. Beart RW Jr, Moertel CG, Wieand HS, Leigh JE, Windschitl HE, van Heerden JA, Fitzgibbons RJ Jr, Wolff BG: Adjuvant therapy for resectable colorectal carcinoma with fluorouracil administered by portal vein infusion. A study of the Mayo Clinic and the North Central Cancer Treatment Group. Arch Surg 1990;125:897-901.
29. Fielding LP, Hittinger R, Grace RH, Fry JS: Randomised controlled trial of adjuvant chemotherapy by portal-vein perfusion after curative resection of colorectal adenocarcinoma. Lancet 1992;340:502-506.
30. Higgins GA Jr, Amadeo JH, McCaughan JJ, Keehn RJ: Efficacy of prolonged intermittend therapy with combined 5-fluorouracil and methyl-CCNU following resection for carcinoma of the large bowel. A Veterans Administration Surgical Oncology Group report. Cancer 1984;53: 1-8.
31. Gastrointestinal Tumor Study Group: Adjuvant therapy of colon cancer, results of a prospectively randomized trial. N Engl J Med 1984;310:737-743.
32. Mansour E, Ryan L, Lerner H, Comis R, Haller O, Ramirez G, Jacquotte A, Douglass H: Lack of effectiveness of 5-FU and methyl-CCNU as compared to 5-FU for adjuvant therapy of colon cancer. Proc ASCO 1989;8:115.
33. Panettiere FJ, Goodman PJ, Constanzi JJ, Cruz A, Vaitkevecius VK, McCracken JD, Brownlee RW, Laufman L, Stephens RL, Bonnet J, Bottomley R, Rivkin SE, Fletcher WS, Oishi N, Chen TT: Adjuvant therapie in large bowel adenocarcinoma: Long-term results of the Southwest Oncology Group study. J Clin Oncol 1988;6:947-954.
34. Higgins GA, Donaldson RC, Rogers LS, Juler GL, Keehn RJ: Efficacy of MER immunotherapy when added to a regimen of 5-fluorouracil and methyl-CCNU following resection for carcinoma of the large bowel. A Veterans Administration Surgical Oncology Group report. Cancer 1984;54:193-198.
35. Mavligit GM, Gutterman JU, Malahy MA, et al: Adjuvant immunotherapy and chemoimmunotherapy in colorectal cancer. Cancer 1977; 40:2726-2730.
36. Hoover HC Jr, Brandhorst JS, Peters LC, Surdyke MG, Takeshita Y, Madariaga J, Muenz LR, Hanna MGJ: Adjuvant active specific immunotherapy for human colorectal cancer: 6,5-year median follow-up of a phase III prospectively randomized trial. J Clin Oncol 1993;11:390-399.
37. Lehner B, Schlag P, Lieblich W, Schirrmacher V: Postoperative active specific immunization in curatively resected colorectal cancer patients with a virus-modified autologous tumor cell vaccine. Cancer Immunol Immunother 1990;32:173-178.
38. Bohle W, Schlag P, Liebrich W, Hohenberger P, Manasterski M, Moller P, Schirrmacher V: Post-operative active specific immunization in colorectal cancer patients with virus-modified autologous tumor-cell vaccine. First clinical results with tumor-cell vaccines modified with live but avirulent Newcastle disease virus. Cancer 1990;66:1517-1523.
39. Schackert HK, Frost P: Gentherapie maligner Tumoren. Chirurg 1993;64:678-683.
40. Schlag PM: Surgical and adjuvant attempts to reduce metastases in colon cancer. Onkologie 1991;14:108-112.
41. O'Connell MJ, Wiesenfeld M, Wienand HS, et al: Interferon-gamma (IFN-8) as postoperative surgical adjuvant therapy for colon cancer: Significant immune stimulation without evidence of therapeutic benefit. Proc ASCO 1992;11:167.
42. Riethmüller G, Schneider Gadicke E, Schlimok G, Schmiegel W, Raab R, Hoffken K, Gruber R, Pichlmaier H, Hirche H, Pichlmayr R, et al: Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group. Lancet 1994;343:1177-1183.
43. Wiggers T, Arends JW, Volovics A: Regression analysis of prognostic factors in colorectal cancer after curative resections. Dis Colon Rectum 1988;31:33-41.
44. Glass RE, Ritchie JK, Thompson HR, Mann CV: The results of surgical treatment of cancer of the rectum by radical resection and extended abdominoiliac lymphadenectomy. Br J Surg 1985;72: 599-601.
45. Surtees P, Ritchie JK, Phillips RK: High versus low ligation of the inferior mesenteric artery in rectal cancer. Br J Surg 1990;77:618-621.
46. Stahle E, Glimelius B, Bergström R, Pahlman L: Preoperative clinical and pathological variables in prognostic evaluation of patients with rectal cancer. A prospective study of 327 consecutive patients. Acta Chir Scand 1988;154:231-239.
47. Michelassi F, Block GE, Vannucci L, Montag A, Chappell R: A 5- to 21-year follow-up and analysis of 250 patients with rectal adenocarcinoma. Ann Surg 1988; 208: 379-388.
48. Feil W, Wunderlich M, Kovats E, Neuhold N, Schemper M, Wenzl E, Schiessel R: Rectal cancer: Factors influencing the development of local recurrence after radical anterior resection. Int J Colorectal Dis 1988;3:195-200.
49. Minsky BD, Mies C, Recht A, Rich T, Chaffey JT: Resectable adenocarcinoma of the rectosigmoid and rectum. II. The influence of blood vessel invasion. Cancer 1988;61:1417-1424.
50. Zirngibl H, Husemann B, Hermanek P: Intraoperative spillage of tumor cells in surgery for rectal cancer. Dis Colon Rectum 1990;33:610-614.
51. Gastrointestinal Tumor Study Group: Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med 1985; 1465-1472.
52. Douglass HO, Moertel CG, Mayer RJ, Thomas PRM, Lindblad AS, Mittleman A, Stablein DM, Bruckner HW: Survival after postoperative combination treatment of rectal cancer. N Engl J Med 1986;315:1294-1295.
53. Fisher B, Wolmark N, Rockette H, Redmond C, Deutsch M, Wickerham DL, Fisher ER, Caplan R, Jones J, Lerner H, Gordon P, Feldman M, Cruz A, Legault-Poisson S, Wexler M, Lawrence W, Robidoux A, NSABP: Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: Results from NSABP Protocol R-01. J Natl Cancer Inst 1988;80:21-29.
54. Krook JE, Moertel CG, Gunderson LL, Wieand HS, Collins RT, Beart RW, Kubista TP, Poon MA, Meyers WC, Mailliard JA, et al: Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991;324:709-715.
55. Gastrointestinal Tumor Study Group: Radiation therapy and fluorouracil with or without semustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum. Gastrointestinal Tumor Study Group. J Clin Oncol 1992;10:549-557.
56. Anonymous: NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990;264:1444-1450.
57. Vaupel P: Oxygenation of human tumors. Strahlenther Onkol 1990;166:377-386.
58. Minsky BD, Cohen AM, Kemeny N, Enker WE, Kelsen DP, Reichman B, Saltz L, Sigurdson ER, Frankel J: Combined modality therapy of rectal cancer: Decreased acute toxicity with the preoperative approach. J Clin Oncol 1992;10:1218-1224.
59. Marks G, Mohiuddin M, Eitan A, Masoni L, Rakinic J: High-dose preoperative radiation and radical sphincter-preserving surgery for rectal cancer. Arch Surg 1991;126:1534-1540.
60. Mohiuddin M, Marks G, Bannon J: High-dose preoperative radiation and full thickness local excision: A new option for selected T3 distal rectal cancers. Int J Radiat Oncol Biol Phys 1994; 30:845-849.
61. Dosoretz DE, Gunderson LL, Hedberg S, Hoskins B, Blitzer PH, Shipley W, Cohen A: Preoperative irradiation for unresectable rectal and rectosigmoid carcinomas. Cancer 1983;52:814-818.
62. Willett CG, Shellito PC, Tepper JE, Eliseo R, Convery K, Wood W: Intraoperative electron beam radiation therapy for recurrent locally advanced rectal or rectosigmoid carcinoma. Cancer 1991;67:1504-1508.
63. Willett CG, Shellito PC, Tepper JE, Eliseo R, Convery K, Wood WC: Intraoperative electron beam radiation therapy for primary locally advanced rectal and rectosigmoid carcinoma. J Clin Oncol 1991;9:843-849.
64. Whiting JF, Howes A, Osteen RT: Preoperative irradiation for unresectable carcinoma of the rectum. Surg Gynecol Obstet 1993;176:203-207.
65. Fowler JF: The linear quadratic formula and progress in fractionated radiotherapy - a review. Br J Radiol 1989;62:679-694.
66. Roswit B, Higgins GA, Keehn RJ: Preoperative irradiation for carcinoma of the rectum and rectosigmoid colon: Report of a national veterans administration randomized study. Cancer 1975; 35:1597-1602.
67. Rider WD, Palmer JA, Mahoney LJ, Robertson CT: Preoperative irradiation in operable cancer of the rectum: Report of the Toronto trial. Can J Surg 1977;20:335-338.
68. Higgins GA, Humphrey EW, Dwight RW, Roswith B, Lee LE, Keehn RJ: Preoperative radiation and surgery for cancer of the rectum. Veterans Administration Surgical Oncology Group Trial II. Cancer 1986;58:352-359.
69. Gerard A, Buyse M, Nordlinger B, Loygue J, Pene F, Kempf P, Bosset JF, Gignoux M, Arnaud JP, Desaive C, et al: Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC). Ann Surg 1988;208:606-614.
70. Stockholm Rectal Cancer Study Group: Preoperative short-term radiation therapy in operable rectal carcinoma. A prospective randomized trial. Cancer 1990;66:49-55.
71. Dahl O, Horn A, Morild I, Halvorsen JF, Odland G, Reinertsen S, Reisaeter A, Kavli H, Thunold J: Low-dose preoperative radiation postpones reccurences in operable rectal cancer. Results of a randomized multicenter trial in western Norway. Cancer 1990;66:2286-2294.
72. Cedermark B, Johansson H, Rutqvist LE, Wilking N, Stockholm Colorectal Cancer Study Group: The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma. A prospective randomized trial. Cancer 1995;75:2269-2275.
73. Palazzo L, Roseau G, Gayet B, Vilgrain V, Belghiti J, Fekete F, Paolaggi JA: Endoscopic ultrasonography in the diagnosis and staging of pancreatic adenocarcioma. Endoscopy 1993;25: 143-150.
74. Boulis Wassif S, Gerard A, Loygue J, Camelot D, Buyse M, Duez N: Final results of a randomized trial on the treatment of rectal cancer with preoperative radiotherapy alone or in combination with 5-fluorouracil, followed by radical surgery. Trial of the European Organization on Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group. Cancer 1984;53: 1811-1818.
75. Pahlman L: Initial report from a Swedish multicentre study examining the role of preoperative irradiation in the treatment of patients with resectable rectal carcinoma. Br J Surg 1993;80: 1333-1336.
76. Frykholm G, Glimelius B, Pahlman L: Preoperative irridiation with or without chemotherapy (MFL) in the treatment of primarily nonresectable adenocarcinoma of the rectum. Results from two consecutive studies. Eur J Cancer Clin Oncol 1989;25:1535-1541.
77. Minsky BD, Kemeny N, Cohen AM, et al: Preoperative high-dose leucovorin/5-fluorouracil and radiation therapy for unresectable rectal cancer. Cancer 1991;67:2859-2866.
78. Minsky BD, Cohen AM, Kemeny N, Enker WE, Kelsen DP, Schwartz GK, Saltz L, Dougherty J, Frankel J, Wiseberg J: Pre-operative combined 5-FU, low dose leucovorin, and sequential radiation therapy for unresectable rectal cancer. Int J Radiat Oncol Biol Phys 1993;25:821-827.
79. Minsky BD, Cohen AM, Kemeny N, Enker WE, Kelsen DP, Saltz L, Frankel J: The efficacy of preoperative 5-fluorouracil, high-dose leucovorin, and sequential radiation therapy for unresectable rectal cancer. Cancer 1993;71:3486-3492.
80. Berdov BA, Menteshashvili GZ: Thermoradiotherapy of patients with locally advanced carcinoma of the rectum. Int J Hyperthermia 1990;6: 881-890.
81. Nishimura Y, Hiraoka M, Akuta K, Jo S, Nagata Y, Masunaga S, Takahashi M, Abe M: Hyperthermia combined with radiation therapy for primarily unresectable and recurrent colorectal cancer. Int J Radiat Oncol Biol Phys 1992;23: 759-768.
82. You QS, Wang RZ, Suen GQ, Yan FC, Gao YJ, Cui SR, Zhao JH, Zhao TZ, Ding L: Combination preoperative radiation and endocavitary hyperthermia for rectal cancer: Long-term results of 44 patients. Int J Hyperthermia 1993; 9:19-24.
83. Feldmann HJ, Molls M, Adler S, Meyer-Schwickerath M, Sack H: Hyperthermia in eccentrically located pelvic tumors: Excessive heating of the perineal fat and normal tissue temperatures. Int J Radiat Oncol Biol Phys 1991;20:1017-1022.
84. Wust P, Rau B, Gremmler M, Schlag P, Jordan A, Loeffel J, Riess H, Felix R: Radio-thermotherapy in multimodal surgical treatment concepts. Onkologie 1995;18:110-121.
85. Chen E, Mohiuddin M, Brodovsky H, Fishbein G, Marks G: Downstaging of advanced rectal cancer following combined preoperative chemotherapy and hig dose radiation. Int J Radiat Oncol Biol Phys 1994;30:169-175.
86. Chan A, Wong A, Langevin J, Khoo R: Preoperative concurrent 5-fluorouracil infusion, mitomycin C and pelvic radiation therapy in tethered and fixed rectal carcinoma. Int J Radiat Oncol Biol Phys 1993;25:791-799.